New technologies and Amyotrophic Lateral Sclerosis – Which step forward rushed by the COVID-19 pandemic?

Susana Pinto, Stefano Quintarelli, Vincenzo Silani

Research output: Contribution to journalReview articlepeer-review

Abstract

Amyotrophic Lateral Sclerosis (ALS) is a fast-progressive neurodegenerative disease leading to progressive physical immobility with usually normal or mild cognitive and/or behavioural involvement. Many patients are relatively young, instructed, sensitive to new technologies, and professionally active when developing the first symptoms. Older patients usually require more time, encouragement, reinforcement and a closer support but, nevertheless, selecting user-friendly devices, provided earlier in the course of the disease, and engaging motivated carers may overcome many technological barriers. ALS may be considered a model for neurodegenerative diseases to further develop and test new technologies. From multidisciplinary teleconsults to telemonitoring of the respiratory function, telemedicine has the potentiality to embrace other fields, including nutrition, physical mobility, and the interaction with the environment. Brain-computer interfaces and eye tracking expanded the field of augmentative and alternative communication in ALS but their potentialities go beyond communication, to cognition and robotics. Virtual reality and different forms of artificial intelligence present further interesting possibilities that deserve to be investigated. COVID-19 pandemic is an unprecedented opportunity to speed up the development and implementation of new technologies in clinical practice, improving the daily living of both ALS patients and carers. The present work reviews the current technologies for ALS patients already in place or being under evaluation with published publications, prompted by the COVID-19 pandemic.

Original languageEnglish
Article number117081
JournalJournal of the Neurological Sciences
Volume418
DOIs
Publication statusPublished - Nov 15 2020

Keywords

  • Amyotrophic lateral sclerosis
  • Artificial intelligence
  • Brain-computer interfaces
  • COVID-19
  • Eye-tracking
  • Robotics
  • Telemedicine
  • Virtual reality

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Fingerprint Dive into the research topics of 'New technologies and Amyotrophic Lateral Sclerosis – Which step forward rushed by the COVID-19 pandemic?'. Together they form a unique fingerprint.

Cite this